[Form 4] Insmed, Inc. Insider Trading Activity
Insmed insider stock sales totaling 10,000 shares were reported. The reporting person, identified as Chief People Strategy Officer and an officer/director, sold 3,554 shares at a weighted average around $126.57, 5,746 shares at a weighted average around $127.71, and 700 shares at a weighted average around $128.16, all on 08/14/2025. After these transactions the reporting person beneficially owned 79,764 shares.
The record shows specific price ranges for each block of shares sold and that 357 of the remaining shares were acquired through the company鈥檚 2018 Employee Stock Purchase Plan. The filing includes a signed power of attorney for the submission. All details are reported on Form 4 and limited to these transactions and resulting ownership.
Sono state segnalate vendite di azioni insider di Insmed per un totale di 10.000 azioni. La persona che ha effettuato la comunicazione, identificata come Chief People Strategy Officer e anche dirigente/direttore, ha venduto 3.554 azioni a un prezzo medio ponderato di circa 126,57 USD, 5.746 azioni a un prezzo medio ponderato di circa 127,71 USD e 700 azioni a un prezzo medio ponderato di circa 128,16 USD, tutte in data 14/08/2025. Dopo queste operazioni la persona dichiarante possedeva beneficiariamente 79.764 azioni.
Il registro indica gli intervalli di prezzo specifici per ciascun blocco di azioni vendute e che 357 delle azioni rimanenti erano state acquisite tramite il Piano di Acquisto Azionario dei Dipendenti 2018 della societ脿. La comunicazione include una procura firmata per l'invio. Tutti i dettagli sono riportati nel Modulo 4 e si limitano a queste transazioni e alla conseguente partecipazione azionaria.
Se informaron ventas de acciones internas de Insmed por un total de 10.000 acciones. La persona informante, identificada como Chief People Strategy Officer y tambi茅n oficial/director, vendi贸 3.554 acciones a un precio medio ponderado de aproximadamente 126,57 USD, 5.746 acciones a un precio medio ponderado de aproximadamente 127,71 USD y 700 acciones a un precio medio ponderado de aproximadamente 128,16 USD, todas el 14/08/2025. Tras estas transacciones, la persona informante pose铆a beneficiariamente 79.764 acciones.
El registro muestra rangos de precio espec铆ficos para cada lote de acciones vendidas y que 357 de las acciones restantes se adquirieron a trav茅s del Plan de Compra de Acciones para Empleados 2018 de la compa帽铆a. La presentaci贸n incluye un poder firmado para la remisi贸n. Todos los detalles figuran en el Formulario 4 y se limitan a estas transacciones y a la propiedad resultante.
Insmed 雮措秬鞛� 欤检嫕 毵る弰 齑� 10,000欤缄皜 氤搓碃霅橃棃鞀惦媹雼�. 氤搓碃鞚胳潃 Chief People Strategy Officer鞚挫瀽 鞛勳洂/鞚挫偓搿� 頇曥澑霅橂┌, 2025-08-14鞐� 臧�欷戫弶攴� 鞎� 126.57雼煬鞐� 3,554欤�, 臧�欷戫弶攴� 鞎� 127.71雼煬鞐� 5,746欤�, 臧�欷戫弶攴� 鞎� 128.16雼煬鞐� 700欤茧ゼ 毵る弰頄堨姷雼堧嫟. 鞚� 瓯半灅 頉� 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 79,764欤茧ゼ 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�.
旮半鞐愲姅 臧� 毵る弰 敫旊鞚� 甑泊鞝� 臧�瓴� 氩旍渼臧� 響滌嫓霅橃柎 鞛堨溂氅�, 雮晞 鞛堧姅 欤检嫕 欷� 357欤茧姅 須岇偓鞚� 2018 歆侅洂 欤检嫕 毵れ瀰 瓿勴殟(ESPP)鞚� 韱淀暣 旆摑霅� 瓴冹溂搿� 雮橃樀雼堧嫟. 鞝滌稖 靹滊鞐愲姅 鞝滌稖鞚� 鞙勴暅 靹滊獏霅� 鞙勳瀯鞛ル弰 韽暔霅橃柎 鞛堨姷雼堧嫟. 氇摖 靹鸽秬靷暛鞚� Form 4鞐� 氤搓碃霅橃柎 鞛堨溂氅� 頃措嫻 瓯半灅鞕� 瓴瓣臣鞝� 靻岇湢甓岇溂搿� 鞝滍暅霅╇媹雼�.
Des ventes d'actions d'initi茅s d'Insmed pour un total de 10 000 actions ont 茅t茅 d茅clar茅es. La personne d茅clarante, identifi茅e comme Chief People Strategy Officer et dirigeant/membre du conseil, a vendu le 14/08/2025 3 554 actions 脿 un prix moyen pond茅r茅 d'environ 126,57 USD, 5 746 actions 脿 un prix moyen pond茅r茅 d'environ 127,71 USD et 700 actions 脿 un prix moyen pond茅r茅 d'environ 128,16 USD. Apr猫s ces op茅rations, la personne d茅clarante d茅tenait b茅n茅ficiairement 79 764 actions.
Le registre indique des fourchettes de prix sp茅cifiques pour chaque lot vendu et pr茅cise que 357 des actions restantes ont 茅t茅 acquises via le Plan d'Achat d'Actions Employ茅s 2018 de la soci茅t茅. Le dossier comprend une procuration sign茅e pour la soumission. Tous les d茅tails figurent dans le Formulaire 4 et se limitent 脿 ces transactions et 脿 la propri茅t茅 qui en r茅sulte.
Insmed-Insider-Verk盲ufe in H枚he von insgesamt 10.000 Aktien wurden gemeldet. Die meldende Person, ausgewiesen als Chief People Strategy Officer und zugleich F眉hrungskraft/Director, verkaufte am 14.08.2025 3.554 Aktien zu einem gewichteten Durchschnittspreis von rund 126,57 USD, 5.746 Aktien zu etwa 127,71 USD und 700 Aktien zu rund 128,16 USD. Nach diesen Transaktionen hielt die meldende Person wirtschaftlich 79.764 Aktien.
Das Register gibt f眉r jede ver盲u脽erte Aktienposition spezifische Preisspannen an und vermerkt, dass 357 der verbleibenden Aktien 眉ber den Employee Stock Purchase Plan 2018 des Unternehmens erworben wurden. Die Einreichung enth盲lt eine unterzeichnete Vollmacht f眉r die 脺bermittlung. Alle Angaben sind im Formular 4 verzeichnet und beschr盲nken sich auf diese Transaktionen und das daraus resultierende Eigentum.
- Reporting person retains a sizeable stake of 79,764 shares after the sales, including 357 shares from the 2018 ESPP
- Insider sold a total of 10,000 shares in three transactions on 08/14/2025, which may be interpreted by some investors as reduced insider exposure
- Sales executed at market prices with weighted averages between approximately $126.57 and $128.16, reducing the insider's share count from 86,210 to 79,764 as reported
Insights
TL;DR: Officer sold 10,000 shares in three blocks; ownership now ~79,764 shares.
The filing documents routine open-market sales by an officer/director rather than option exercises or transfers. The three sale blocks total 10,000 shares with weighted average prices in a narrow $126鈥�$128 range, suggesting marketed sales rather than single-block negotiated transactions. Retaining 79,764 shares keeps the reporting person as a meaningful, but reduced, insider holder. From a governance perspective, these are ordinary disclosures; the filing does not indicate hedging, loans, or related-party transfers that would raise additional governance flags.
TL;DR: Sales are material for the individual but present no disclosed extraordinary risk to the issuer.
The transaction size (10,000 shares) and prices are explicitly reported with ranges and weighted averages. The filing notes 357 shares from an Employee Stock Purchase Plan remain included in beneficial ownership. There is no reference to a Rule 10b5-1 plan or insider trading defense on this form, and no derivative or hedging instruments are reported. Based solely on the disclosed items, this is a straightforward insider sale with clear post-sale ownership figures; it does not by itself indicate company-level financial stress or material corporate events.
Sono state segnalate vendite di azioni insider di Insmed per un totale di 10.000 azioni. La persona che ha effettuato la comunicazione, identificata come Chief People Strategy Officer e anche dirigente/direttore, ha venduto 3.554 azioni a un prezzo medio ponderato di circa 126,57 USD, 5.746 azioni a un prezzo medio ponderato di circa 127,71 USD e 700 azioni a un prezzo medio ponderato di circa 128,16 USD, tutte in data 14/08/2025. Dopo queste operazioni la persona dichiarante possedeva beneficiariamente 79.764 azioni.
Il registro indica gli intervalli di prezzo specifici per ciascun blocco di azioni vendute e che 357 delle azioni rimanenti erano state acquisite tramite il Piano di Acquisto Azionario dei Dipendenti 2018 della societ脿. La comunicazione include una procura firmata per l'invio. Tutti i dettagli sono riportati nel Modulo 4 e si limitano a queste transazioni e alla conseguente partecipazione azionaria.
Se informaron ventas de acciones internas de Insmed por un total de 10.000 acciones. La persona informante, identificada como Chief People Strategy Officer y tambi茅n oficial/director, vendi贸 3.554 acciones a un precio medio ponderado de aproximadamente 126,57 USD, 5.746 acciones a un precio medio ponderado de aproximadamente 127,71 USD y 700 acciones a un precio medio ponderado de aproximadamente 128,16 USD, todas el 14/08/2025. Tras estas transacciones, la persona informante pose铆a beneficiariamente 79.764 acciones.
El registro muestra rangos de precio espec铆ficos para cada lote de acciones vendidas y que 357 de las acciones restantes se adquirieron a trav茅s del Plan de Compra de Acciones para Empleados 2018 de la compa帽铆a. La presentaci贸n incluye un poder firmado para la remisi贸n. Todos los detalles figuran en el Formulario 4 y se limitan a estas transacciones y a la propiedad resultante.
Insmed 雮措秬鞛� 欤检嫕 毵る弰 齑� 10,000欤缄皜 氤搓碃霅橃棃鞀惦媹雼�. 氤搓碃鞚胳潃 Chief People Strategy Officer鞚挫瀽 鞛勳洂/鞚挫偓搿� 頇曥澑霅橂┌, 2025-08-14鞐� 臧�欷戫弶攴� 鞎� 126.57雼煬鞐� 3,554欤�, 臧�欷戫弶攴� 鞎� 127.71雼煬鞐� 5,746欤�, 臧�欷戫弶攴� 鞎� 128.16雼煬鞐� 700欤茧ゼ 毵る弰頄堨姷雼堧嫟. 鞚� 瓯半灅 頉� 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 79,764欤茧ゼ 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�.
旮半鞐愲姅 臧� 毵る弰 敫旊鞚� 甑泊鞝� 臧�瓴� 氩旍渼臧� 響滌嫓霅橃柎 鞛堨溂氅�, 雮晞 鞛堧姅 欤检嫕 欷� 357欤茧姅 須岇偓鞚� 2018 歆侅洂 欤检嫕 毵れ瀰 瓿勴殟(ESPP)鞚� 韱淀暣 旆摑霅� 瓴冹溂搿� 雮橃樀雼堧嫟. 鞝滌稖 靹滊鞐愲姅 鞝滌稖鞚� 鞙勴暅 靹滊獏霅� 鞙勳瀯鞛ル弰 韽暔霅橃柎 鞛堨姷雼堧嫟. 氇摖 靹鸽秬靷暛鞚� Form 4鞐� 氤搓碃霅橃柎 鞛堨溂氅� 頃措嫻 瓯半灅鞕� 瓴瓣臣鞝� 靻岇湢甓岇溂搿� 鞝滍暅霅╇媹雼�.
Des ventes d'actions d'initi茅s d'Insmed pour un total de 10 000 actions ont 茅t茅 d茅clar茅es. La personne d茅clarante, identifi茅e comme Chief People Strategy Officer et dirigeant/membre du conseil, a vendu le 14/08/2025 3 554 actions 脿 un prix moyen pond茅r茅 d'environ 126,57 USD, 5 746 actions 脿 un prix moyen pond茅r茅 d'environ 127,71 USD et 700 actions 脿 un prix moyen pond茅r茅 d'environ 128,16 USD. Apr猫s ces op茅rations, la personne d茅clarante d茅tenait b茅n茅ficiairement 79 764 actions.
Le registre indique des fourchettes de prix sp茅cifiques pour chaque lot vendu et pr茅cise que 357 des actions restantes ont 茅t茅 acquises via le Plan d'Achat d'Actions Employ茅s 2018 de la soci茅t茅. Le dossier comprend une procuration sign茅e pour la soumission. Tous les d茅tails figurent dans le Formulaire 4 et se limitent 脿 ces transactions et 脿 la propri茅t茅 qui en r茅sulte.
Insmed-Insider-Verk盲ufe in H枚he von insgesamt 10.000 Aktien wurden gemeldet. Die meldende Person, ausgewiesen als Chief People Strategy Officer und zugleich F眉hrungskraft/Director, verkaufte am 14.08.2025 3.554 Aktien zu einem gewichteten Durchschnittspreis von rund 126,57 USD, 5.746 Aktien zu etwa 127,71 USD und 700 Aktien zu rund 128,16 USD. Nach diesen Transaktionen hielt die meldende Person wirtschaftlich 79.764 Aktien.
Das Register gibt f眉r jede ver盲u脽erte Aktienposition spezifische Preisspannen an und vermerkt, dass 357 der verbleibenden Aktien 眉ber den Employee Stock Purchase Plan 2018 des Unternehmens erworben wurden. Die Einreichung enth盲lt eine unterzeichnete Vollmacht f眉r die 脺bermittlung. Alle Angaben sind im Formular 4 verzeichnet und beschr盲nken sich auf diese Transaktionen und das daraus resultierende Eigentum.
FAQ
What transactions did INSM insider S. Nicole Schaeffer report on Form 4?
How many Insmed (INSM) shares does the reporting person own after these sales?
Did the Form 4 disclose any derivative transactions or hedging for INSM?
Are any of the remaining shares from an employee plan?
Does the filing indicate sales were made under a Rule 10b5-1 plan?
